Nutrition
Volume 25, Issue 11 , Pages 1073-1084 , November 2009

Trace element supplementation in parenteral nutrition: Pharmacy, posology, and monitoring guidance

  • Gil Hardy, Ph.D., F.R.S.C.

      Affiliations

    • Institute of Food, Nutrition and Human Health, Massey University, Auckland, New Zealand
    • ,
  • Ana Maria Menendez, B.Pharm.

      Affiliations

    • Instituto Argentino de Educación e Investigación en Nutricion, Buenos Aires, Argentina
    • ,
  • William Manzanares, M.D.

      Affiliations

    • Department of Critical Care Medicine, School of Medicine, Universidad de la República, Montevideo, Uruguay
    • Corresponding Author InformationCorresponding author. Tel.: +598-2-480-6180; fax: +598-2-487-7213.

Received 19 December 2008 ,Accepted 19 March 2009.

References and recommended reading 

  1. National Institute for Health and Clinical Excellence. Nutrition support in adults: oral nutrition support, enteral tube feeding and parenteral nutrition; 2006 Available at: www.rcseng.ac.uk/publications/docs/nutrition_support_guidelines.html/view. Accessed December 2008.
  2. Mertz W. Review of the scientific basis for establishing the essentiality of trace elements. Biol Trace Elem Res. 1998;66:185–191
  3. Standing Committee on the Scientific Evaluation of Dietary References Intakes, Food and Nutrition Board, and Institute of Medicine Dietary references intakes (DRI) for calcium, phosphorus, magnesium, vitamin D and fluoride. Washington, DC: National Academy of Sciences; 1997;
  4. Standing Committee on the Scientific Evaluation of Dietary References Intakes, Food and Nutrition Board, and Institute of Medicine Dietary references intakes (DRI) for thiamin, riboflavin, vitamin B6, niacin, folate, vitamin B12 and choline. Washington, DC: National Academy of Sciences; 1998;
  5. Standing Committee on the Scientific Evaluation of Dietary References Intakes, Food and Nutrition Board, Institute of Medicine Antioxidants' role in chronic disease prevention still uncertain; huge doses considered risky. Washington, DC: National Academy of Sciences; 2000;
  6. Standing Committee on the Scientific Evaluation of Dietary References Intakes, Food and Nutrition Board, and Institute of Medicine Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, molybdenum, nickel, silicon, vanadium and zinc. Washington, DC: National Academy of Sciences; 2001;
  7. Human vitamin and mineral requirements Water-soluble and fat-soluble vitamins. Calcium, magnesium, iodide, iron, selenium, zinc, antioxidants. Rome: WHO and FAO; 2002;
  8. Allwood MC, Martin H, Greenwood M, Maunder M. Precipitation of trace elements in parenteral nutrition mixtures. Clin Nutr. 1998;17:223–226
  9. Hardy IJ, Martin H, Hardy G. Selenium stability in vitamin and glutamine mixtures. Clin Nutr. 2005;24:596
  10. Ball PA. Intravenous in-line filters: filtering the evidence. Curr Opin Clin Nutr Metab Care. 2003;6:319–325
  11. Report of the Expert Group on Vitamins and Minerals. Statement on the mutagenicity of trivalent Chromium and Chromium picolinate. Com/04/S3—December 2004. Available at: http://www.advisorybodies.doh.gov.uk/com/chromium.htm. Accessed December 2008.
  12. Moukarzel AA, Song MK, Buckman AL, Vargas J, Gass W, McDiarmid M. Excessive chromium intake in children receiving total parenteral nutrition. Lancet. 1992;339:385–388
  13. Tsuda K, Yokoyama Y, Morita M, Nakazawa Y, Onishi S. Selenium and chromium deficiency during long term home parenteral nutrition in chronic idiopathic intestinal pseudo-obstruction. Nutrition. 1998;14:291–295
  14. Ding WJ, Chai ZF, Duan P, Feng W, Qian Q. Serum and urine chromium concentrations in elderly diabetics. Biol Trace Elem Res. 1998;63:231–237
  15. Jeejeebhoy KN, Chu RC, Marliss E, Greenberg GR, Bruce-Robertson A. Chromium deficiency, glucose intolerance and neuropathy reversed by chromium supplementation in a patient receiving long-term PN. Am J Clin Nutr. 1977;30:531–538
  16. Sudhakar M, Kirby DF. Micronutrient and trace element monitoring in adult nutrition support. Nutr Clin Pract. 2000;15:120–126
  17. Via M, Scurlock C, Raikhelkar J, Di Luozzo G, Mechanick JI. Chromium infusion reverses extreme insulin resistance in a cardiothoracic ICU patient. Nutr Clin Pract. 2008;23:325–328
  18. ASPEN Board of Directors and the Clinical Task Force . Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN. 2002;26(suppl):23SA
  19. Shenkin A. Trace elements and vitamins in parenteral and enteral nutrition. In:  Sobotka L editors. Basics in clinical nutrition. 3rd ed. Prague, Czech Republic: Galen; 2004;p. 169–175
  20. Churchwell MD, Pasko DA, Btaiche IF, Jain JC, Mueller BA. Trace element removal during in vitro and in vivo continuous haemodialysis. Nephrol Dial Transplant. 2007;22:2970–2977
  21. Zappitelli M, Juarez M, Castillo L, Coss-Bu J, Goldstein SL. Continuous renal replacement therapy amino acid, trace metal and folate clearance in critically ill children. Intensive Care Med. 2009;35:698–706
  22. Mouser JF, Hak EB, Helms RA, Christensen ML, Storm MC. Chromium and zinc concentrations in pediatric patients receiving long-term parenteral nutrition. Am J Health Syst Pharm. 1999;56:1950–1956
  23. Hardy G, Reilly C. Technical aspects of trace element supplementation. Curr Opin Clin Nutr Metab Care. 1999;2:277–285
  24. Ito Y, Alcock NW, Shils ME. Chromium content of total parenteral nutrition solutions. JPEN. 1990;14:610–614
  25. Vincent JB. Quest for the molecular mechanism of chromium action and its relationship to diabetes. Nutr Rev. 2000;58:67–72
  26. Leung FY. Trace elements in parenteral micro-nutrition. Clin Biochem. 1995;28:561–566
  27. In:  Austin P,  Stroud M editor. Prescribing adult intravenous nutrition. London: Pharmaceutical Press; 2007;
  28. Spiegel J, Willenbucher R. Development of severe copper deficiency in a patient with Crohn's disease receiving parenteral nutrition. JPEN. 1999;23:169–172
  29. Forbes GM, Forbes A. micronutrient status in patients receiving home parenteral nutrition. Nutrition. 1997;13:941–944
  30. Shike M, Roulet M, Kurian R, Whitwell J, Stewart S, Jeejeebhoy KN. Copper metabolism and requirements in total parenteral nutrition. Gastroenterology. 1981;81:290–297
  31. Fujita M, Itakura T, Takagi Y, Okada A. Copper deficiency during total parenteral nutrition: clinical analysis of three cases. JPEN. 1989;13:421–425
  32. Berger MM, Shenkin A. Trace elements in trauma and burns. Curr Opin Clin Nutr Metab Care. 1998;1:513–517
  33. Menéndez AM, Montemerlo H, Weisstaub A, Alloatti S, Rusi F, Guidoni ME, et al. Plasmatic and erythrocytic zinc and cooper levels in critically ill patients on parenteral nutrition and their relationship with formulas content: preliminary results. Nutr Hosp. 2005;20:189–196
  34. Menéndez AM, Weisstaub A, Montemerlo H, Rusi F, Guidoni ME, Piñeiro A, et al. Zinc and cooper content in individual components used to prepare pediatric total nutrition mixtures. Nutr Hosp. 2007;23:545–551
  35. Bergomi M, Rovesti S, Vinceti M, Vivoli R, Caselgrandi E, Vivoli G. Zinc and copper status and blood pressure. J Trace Elem Med Biol. 1997;11:166–199
  36. Turnland JR, Copper . In:  Shils ME,  Shike M,  Ross AC,  Caballero B,  Cousins RJ editor. Modern nutrition in health and disease. 10th ed. Philadelphia: Lippincott Williams & Wilkins; 2005;p. 286–299
  37. National Kidney Foundation Dialysis Outcomes Quality Initiative . Clinical practice guidelines for the treatment of anemia of chronic renal failure: National Kidney Foundation Dialysis Outcomes Quality Initiative: 2000 update. Am J Kidney Dis. 2001;37(suppl 1):S186–S206
  38. Muñoz M, Breymann C, García-Erce JA, Gómez-Ramirez S, Comin J, Bisbe E. Efficacy and safety of intravenous iron therapy as an alternative/adjunct to allogenic blood transfusions. Vox Sang. 2008;94:172–183
  39. Hoen B, Kessler M, Hestin D, Mayeux D. Risk factors for bacterial infections in chronic hemodialysis adult patients: a multicenter prospective survey. Nephrol Dial Transplant. 1995;10:337–381
  40. Weinberg E. Iron and infection. Microbiol Rev. 1978;42:45–66
  41. Tielemans CL, Lenclud CM, Wens R, Collart FE, Dratwa M. Critical role of iron overload in the increased susceptibility of haemodialysis patients to bacterial infections. Beneficial effects of desferrioxamine. Nephrol Dial Transplant. 1989;4:883–887
  42. Swoboda SM, Lipsett PA. Intravenous iron as a risk factor for bacteremia in the surgical intensive care unit patient. Surg Infect. 2005;6:158
  43. Corwin HL, Gettinger A, Fabian TC, May A, Pearl RG, Heard S, et al Efficacy and safety of epoetin alfa in critically ill patients. N Engl J Med. 2007;357:965–976
  44. Napolitano LM, Fabian TC, Kelly KM, Balley JA, Block EF, Langholff W, et al Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. J Trauma. 2008;65:2875–2897
  45. Pieracci FM, Barie PS. Diagnosis and management of iron-related anemias in critical illness. Crit Care Med. 2006;34:1898–1905
  46. Lapointe M. Iron supplementation in the intensive care unit: when, how much, and by what route?. Crit Care. 2004;8(suppl 2):S37–S41
  47. Kumpf VJ. Update on parenteral iron therapy. Nutr Clin Pract. 2003;18:318–326
  48. Danielson BG. Structure, chemistry, and pharmacokinetics of intravenous iron agents. J Am Soc Nephrol. 2004;15:S93–S98
  49. WHO/UNICEF/ICCIDD . Iron deficiency anemia: assessment, prevention and control. WHO/NHD/013 Geneva: World Health Organization; 2001;
  50. Papet I, Meunier N, Béchereau F, Glomot F, Obled C, Coudray C. Effect of zinc supplementation on protein metabolism in late-middle-aged men: the Zenith study. Nutrition. 2008;24:155–161
  51. Sazawal S, Black RE, Jalla S, Mazumdar S, Sinha A, Bhan MK. Zinc supplementation reduces the incidence of acute lower respiratory infections in infants and pre-school children. Pediatrics. 1998;102:1–5
  52. Abu-Hamdan DK, Migdal SD, Whitehouse R, Rabbani P, Prasad AS, McDonald FD. Renal handling of zinc: effect of cysteine infusion. Am J Physiol. 1981;241:F487-94
  53. Cousins R, Hempe JM. Zinc. In:  Brown ML editors. Present knowledge in nutrition. 6th ed. Washington, DC: Nutrition Foundation; 1990;p. 251–260
  54. Braunschweig CL, Sowers M, Kovacevich DS, Hill GM, August DA. Parenteral zinc supplementation in adult humans during the acute phase response increases the febrile response. J Nutr. 1997;127:70–74
  55. Berger MM, Eggimann P, Heyland DK, Chioléro RL, Revelly JP, Day A, et al. Reduction of nosocomial pneumonia after major burns by trace elements supplementation: aggregation of two randomised trials. Crit Care. 2006;10:R153
  56. Agay D, Anderson RA, Sandre C, Bryden NA, Alonso A, Roussel AM, et al. Alterations of antioxidant trace elements (Zn, Se, Cu) and related metallo-enzymes in plasma and tissues following burn injuries in rats. Burns. 2005;31:366–371
  57. Berger MM, Shenkin A. Vitamins and trace elements: practical aspects of supplementation. Nutrition. 2006;22:952–955
  58. Berger MM. Antioxidant micronutrients in major trauma and burns: evidence and practice. Nutr Clin Pract. 2006;21:438–449
  59. Soguel L, Chioléro RL, Ruffieux C, Berger MM. Monitoring the clinical introduction of a glutamine and antioxidant solution in critically ill trauma and burn patients. Nutrition. 2008;24:1123–1132
  60. Menéndez AM, Montemerlo H, Weisstaub A, Alloatti S, Guidoni ME, Rusi F, et al. Relationship between the amount of cooper and zinc given to critically ill patients on total parenteral nutrition and plasma and erythrocyte cooper and zinc levels. Nutr Hosp. 2008;23:373–382
  61. Kohrle J, Brigelius-Flohe R, Bock A, Gärtner R, Meyer O, Flohé L. Selenium in biology: facts and medical perspectives. Biol Chem. 2000;381:849–864
  62. Hardy G, Hardy I. Selenium: the Se-XY nutraceutical. Nutrition. 2004;20:590–593
  63. Dodig S, Cepelak I. The facts and controversy about selenium. Acta Pharm. 2004;54:261–276
  64. Rayman MP. The importance of selenium to human health. Lancet. 2000;356:233–241
  65. Burk RF, Hill KE, Selenoprotein P. an extracellular protein with unique physical characteristics and a role in selenium homeostasis. Annu Rev Nutr. 2005;25:215–235
  66. Duffield AJ, Thomson CD, Hill KE, Williams S. An estimation of selenium requirements for New Zealanders. Am J Clin Nutr. 1999;70:896–903
  67. Thomson CD, Robinson MF, Butler JA, Whanger PD. Long term supplementation with selenate and selenomethionine: selenium and glutathione peroxidase in blood components of New Zealand women. Br J Nutr. 1993;69:577–588
  68. Manzanares W, Biestro A, Galusso F, Torre MH, Mañay N, Pittini G, et al. Serum selenium and glutathione preoxidase-3 activity: biomarkers of systemic inflammation in the critically ill. Intensive Care Med. 2009;35:882–889
  69. Manzanares Castro W. Selenium in critically ill patients with systemic inflammatory response syndrome. Nutr Hosp. 2007;22:295–306
  70. Angstwurm MWA, Engelmann L, Zimmermann T, Lehmann C, Spes CH, Abel P. Selenium in Intensive Care (SIC) study: results of a prospective, randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis and septic shock. Crit Care Med. 2007;35:118–126
  71. Maehira F, Miyagi I, Eguchi Y. Selenium regulates transcription factor NF-kB activation during the acute phase reaction. Clin Chem Acta. 2003;334:163–171
  72. Jeong DW, Yoo MH, Kim TS, Kim JH, Kim IY. Protection of mice from allergen-induced asthma by selenite: prevention of eosinophil infiltration by inhibition of NF-kappa B activation. J Biol Chem. 2002;277:17871–17876
  73. Stewart MS, Spallholz JE, Neldner KH, Pence BC. Selenium compounds have disparate abilities to impose oxidative stress and induce apoptosis. Free Radic Biol Med. 1999;26:42–48
  74. Chung YW, Kim TS, Lee SY, Lee SH, Chol Y, Kim N, et al. Selenite-induced apoptosis of osteoclasts mediated by the mitochondrial pathway. Toxicol Lett. 2006;160:143–150
  75. Forceville X, Laviolle B, Annane D, Vitoux D, Bleichner G, Korach JM, et al. Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study. Crit Care. 2007;11:R73
  76. Vincent JL, Forceville X. Critically elucidating the role of selenium. Curr Opin Anesthesiol. 2008;21:148–154
  77. Heyland DK. Selenium supplementation in critically ill patients: can too much of a good thing be a bad thing?. Crit Care. 2007;11:153
  78. Manzanares W, Torre MH, Biestro A, Galusso F, Mañay N, Pitini G. Pharmacokinetics and pharmacodynamics of high dose selenium in systemic inflammatory response syndrome. Clin Nutr. 2008;3(suppl 1):6–7
  79. Gillanders L, Hardy IJ, Hardy G. Is manganese an essential supplement for parenteral nutrition?. Curr Opin Clin Nutr Metab Care. 2008;11:289–296
  80. Reynolds N, Blumsohn A, Baxter JP, Houston G, Pennington CR. Manganese requirement and toxicity in patients on HPN. Clin Nutr. 1998;17:227–230
  81. Fell JM, Reynolds AP, Meadows N, Khan K, Long SG, Quaghebeur G, et al. Manganese toxicity in children receiving long-term parenteral nutrition. Lancet. 1996;347:1218–1221
  82. Howard L, Ashley C, Lyon D, Shenkin A. Autopsy tissue trace elements in 8 long-term parenteral nutrition patients who received the current US FDA formulation. JPEN. 2007;31:388–396
  83. Dickerson RN. Manganese intoxication and parenteral nutrition. Nutrition. 2001;17:689–693
  84. Takagi Y, Okada A, Sando K, Wasa M, Yoshida H, Hirabuki N. Evaluation of indexes of in vivo manganese status and the optimal intravenous dose for adult patients undergoing home parenteral nutrition. Am J Clin Nutr. 2002;75:112–118
  85. Ocaña M, Hardy G. Trace element contamination of some HPN solutions. Nutrition. 2008;24:508
  86. Johnson JL, Rajagopalan KV, Cohen HJ. Molecular basis of the biologic function of molybdenum. J Biol Chem. 1874;249:859–866
  87. Zhang Z, Naughton D, Winyard PG, Benjamin N, Blake DR, Symons MC. Generation of nitric oxide reductase activity of xanthine oxidase: a potential pathway for nitric oxide formation in the absence of nitric oxide synthase activity. Biochem Biophys Res Comm. 1998;249:767–772
  88. Abrumad NN, Schneider AJ, Steel D, Rogers LS. Amino acid intolerance during prolonged total parenteral nutrition reversed by molybdate therapy. Am J Clin Nutr. 1981;34:2551–2559
  89. Desthale YG, Gopalan C. The effect of molybdenum levels in sorghum on uric acid and copper excretion in man. Br J Nutr. 1974;31:351–355
  90. Berner YN, Shuler ER, Nielsen FH. Selected ultratrace elements in total parenteral nutrition solutions. Am J Clin Nutr. 1989;50:1079–1083
  91. ASPEN Board of Directors . Safe practices in parenteral nutrition. JPEN. 2004;28(suppl):S39–S70

PII: S0899-9007(09)00138-5

doi: 10.1016/j.nut.2009.03.004

Nutrition
Volume 25, Issue 11 , Pages 1073-1084 , November 2009

Article Tools